RxDoctor Payments Data

Nicholas Tuttle, MD

Family Medicine · Rock Hill, SCNPI 1447251186

Payments from drug & device makers

$2,317in general payments, 2019–2025

Across 22 payments — averaging $105.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$976
  • Bayer$243
  • GSK$229
  • Novo Nordisk$226
  • Inspire Medical Systems, Inc.$139
  • AbbVie$125
  • plus $380 from 5 others

What the payments were for

  • Food & beverage$2,317100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,317 in reported general payments places this provider in the 70th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$137,298
Medicare patients
526
Services billed
1,764

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide73$79,754
FarxigaDapagliflozin Propanediol76$66,017
EliquisApixaban46$38,127
JanuviaSitagliptin Phosphate39$29,789
JanumetSitagliptin Phos/Metformin Hcl21$20,611
JardianceEmpagliflozin30$19,615
TrulicityDulaglutide18$19,224
Janumet XrSitagliptin Phos/Metformin Hcl31$18,614
Breo ElliptaFluticasone/Vilanterol44$18,363
MounjaroTirzepatide15$15,907
TradjentaLinagliptin15$11,240
SymbicortBudesonide/Formoterol Fumarate33$8,228
SynthroidLevothyroxine Sodium95$8,129
Advair HfaFluticasone Propion/Salmeterol13$6,420
Omeprazole455$4,901

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$226$79,75473 claims
AstraZenecaFarxiga, Symbicort$976$74,245109 claims
MerckJanuvia, Janumet, Janumet Xr$101$69,01591 claims
GSKBreo Ellipta$229$18,36344 claims
AbbVieSynthroid$125$8,12995 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Rock Hill

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →